ABSTRACT: Californium-252 radioisotopic neutron source capsules have been used for brachytherapy treatment of tumors for nearly 30 years. In the United States, several manually afterloaded low-dose-rate (LDR) source designs have been produced; internationally, only four remotely afterloaded high-dose-rate (HDR) systems are known to have been demonstrated. These HDR systems typically used source capsules with diameters of several millimeters, which restricted their application in treating tumors in geometrically constrained or neurologically sensitive locations. The Californium Program at Oak Ridge National Laboratory (ORNL), in collaboration with Isotron, Inc., is developing a family of miniature HDR 252Cf source designs that will be coupl...
ow-f br 4 bra 10 252 252 moderation of these fast neutrons, there exists the potential to augment 25...
A new generation of medical grade Cf-252 sources was developed in 2002 at the Oak Ridge National Lab...
From eleventh conference on radioisotopes; Tokyo, Japan (13 Nov 1973). The history, production, and ...
Californium-252 neutron brachytherapy (NBT) is extremely effective in causing rapid regression of bu...
This work describes the current status of the US low dose rate (LDR) Cf-252 brachytherapy program. T...
The Gershenson Radiation Oncology Center of Wayne State University (WSU), Detroit, Michigan, is usin...
The radioisotope {sup 252}Cf is routinely encapsulated into compact, portable, intense neutron sourc...
Californium-252 may be used extensively as a new source of neutrons in the next few years. Because o...
The Californium User Facility for Neutron Science has been established at Oak Ridge National Laborat...
A product of the nuclear age, Californium-252 ({sup 252}Cf) has found many applications in medicine,...
Examination of neutron dosimetry for 252Cf has been conducted using calculative and experimental mea...
Simulated sources containing $sup 252$Cf equivalents of 0.1 to 1.0 milligrams were prepared. Samariu...
The Savannah River Laboratory (SRL) is currently producing californium- 252 sources for a medical ev...
In 1995, the American Association of Physicists in Medicine Task Group 43 (AAPM TG-43) published a p...
The radiation dose from 252 Californium needles designed for use as a source of neutrons for radioth...
ow-f br 4 bra 10 252 252 moderation of these fast neutrons, there exists the potential to augment 25...
A new generation of medical grade Cf-252 sources was developed in 2002 at the Oak Ridge National Lab...
From eleventh conference on radioisotopes; Tokyo, Japan (13 Nov 1973). The history, production, and ...
Californium-252 neutron brachytherapy (NBT) is extremely effective in causing rapid regression of bu...
This work describes the current status of the US low dose rate (LDR) Cf-252 brachytherapy program. T...
The Gershenson Radiation Oncology Center of Wayne State University (WSU), Detroit, Michigan, is usin...
The radioisotope {sup 252}Cf is routinely encapsulated into compact, portable, intense neutron sourc...
Californium-252 may be used extensively as a new source of neutrons in the next few years. Because o...
The Californium User Facility for Neutron Science has been established at Oak Ridge National Laborat...
A product of the nuclear age, Californium-252 ({sup 252}Cf) has found many applications in medicine,...
Examination of neutron dosimetry for 252Cf has been conducted using calculative and experimental mea...
Simulated sources containing $sup 252$Cf equivalents of 0.1 to 1.0 milligrams were prepared. Samariu...
The Savannah River Laboratory (SRL) is currently producing californium- 252 sources for a medical ev...
In 1995, the American Association of Physicists in Medicine Task Group 43 (AAPM TG-43) published a p...
The radiation dose from 252 Californium needles designed for use as a source of neutrons for radioth...
ow-f br 4 bra 10 252 252 moderation of these fast neutrons, there exists the potential to augment 25...
A new generation of medical grade Cf-252 sources was developed in 2002 at the Oak Ridge National Lab...
From eleventh conference on radioisotopes; Tokyo, Japan (13 Nov 1973). The history, production, and ...